Abstract
This chapter considers the ethics of the enhancement of cognition in the Convergence initiative. In mature areas of research and development, ethics can be regarded as a specialized domain of practice with its own distinctive expertise. Debate on use of stimulants for enhancement can be taken as representative. Such ethical reflection usually takes for granted the concepts, norms, and ends that govern the development and uses of pharmaceuticals in medical contexts. Instead of engaging these background interpretive frames, ethical analysis tends to focus on potential harms or negative disruptive effects associated with a specific application and is oriented toward mitigating these and renormalizing the practices. In emerging areas such as those contemplated in Convergence initiatives for enhancing cognition, such analysis is not possible. A more complex ethical discourse is required which will be entangled with scientific and technologically oriented reflection on the nature of the cognitive capacities being advanced. This will be illustrated by considering the ways notions of executive function, metacognition, ethical responsibility, and Convergences advancing cognition might be iteratively refined in relation to one another. As a broad effort to understand, foster, and manage emerging practices, Convergence provides a helpful framework for cultivating long needed reforms in the way ethical analysis and policy are approached. At the same time, cultivation of a full ethics of Convergence adds something that is missing from the current Convergence efforts. A richer convergence of Convergence and ethics would thus be mutually beneficial for both forms of second-order reflection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ardila A (2008) On the evolutionary origins of executive functions. Brain Cogn 68:92–99
Aristotle (2011) Nicomachean ethics (trans: Bartlett RC, Collins SD). University of Chicago Press, Chicago
Benford RD, Snow DA (2000) Framing processes and social movements: an overview and assessment. Annu Rev Sociol 26(6):611–639
Canguilhem G (1991) The normal and the pathological. Zone Books, New York
Capek SM (1993) The ‘environmental justice’ frame: a conceptual discussion and application. Soc Probl 40(1):5–24
Castellanos FX, Sonuga-Parke EJS, Milham MP, Tannock R (2006) Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cogn Sci 10(3):117–123
Chan RCK, Shum D, Toulopoulou T, Chen EYH (2008) Assessment of executive functions: review of instruments and identification of critical issues. Arch Clin Neuropsychol 23:201–216
Clark A (2003) Natural-born cyborgs: minds, technologies, and the future of human intelligence. Oxford University Press, Oxford
Clark A (2007) Re-inventing ourselves: the plasticity of embodiment, sensing, and mind. J Med Philos 32(3):263–282
Collins H, Evans R, Goreman M (2007) Trading zones and interactional expertise. Stud Hist Philos Sci 39(1):657–666
De Jongh R, Bolt I, Schermer M, Olivier B (2008) Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neurosci Biobehav Rev 32:760–776
Fernandez-Duque D, Baird JA, Posner MI (2000) Executive attention and metacognitive regulation. Conscious Cogn 9:288–307
Goffman E (1974) Frame analysis: an essay on the organization of the experience. Harper Colophon, New York
Gordijn B, Chadwick R (eds) (2008) Medical enhancement and posthumanity. Springer, Dordrecht
Karbach J, Kray J (2009) How useful is executive control training? Age differences in near and far transfer of task-switching training. Dev Sci 12(6):978–990
Khushf G (2004) Systems theory and the ethics of human enhancement: a framework for NBIC convergence. In: Roco M, Montemagno CD (eds) The coevolution of human potential and converging technologies, vol 1013. Annals of the New York Academy of Sciences, New York, pp 124–149
Khushf G (2005) The use of emergent technologies for enhancing human performance: are we prepared to address the ethical and policy issues. Public Policy Pract 4(2):1–17
Khushf G (2009) Open evolution and human agency: the pragmatics of upstream ethics in the design of artificial life. In: Bedau MA, Parke EC (eds) The ethics of protocells: moral and social implications of creating life in the laboratory. MIT Press, Cambridge, MA, pp 223–262
Khushf G (2011) The ethics of nano-neuro convergence. In: Illes J, Sahakian B (eds), and Federico C, Morein-Zamir S (Assoc. eds) The Oxford handbook of neuroethics. Oxford University Press, Oxford, pp 467–492
Khushf G, Siegel R (2012) What is unique about nanomedicine? The significance of the meso-scale. J Law Med Ethics 40:780–794
Levin IP, Schneider SL, Gaeth GJ (1998) All frames are not created equal: a typology and critical analysis of framing effects. Organ Behav Hum Decis Process 76(2):149–188
Livingston J (1997) Metacognition: an overview. Available at http://www.researchgate.net/profile/Jennifer_Livingston/publication/234755498_Metacognition_An_Overview/links/0fcfd5112609b7ced5000000.pdf. Downloaded 15 June 2015
MacIntyre A (1984) After virtue: a study in moral theory, 2nd edn. University of Notre Dame Press, Notre Dame
MacIntyre A (1988) Whose justice? Which rationality? University of Notre Dame Press, Notre Dame
Nordmann A (2007) Knots and strands: an argument for productive disillusionment. J Med Philos 32(3):217–236
Nordmann A (Repporteur) (2004) Converging technologies: shaping the future of European societies. Available at http://cordis.europa.edu/foresight/ntw_expert_group.htm
Outram SM (2012) Ethical considerations in the framing of the cognitive enhancement debate. Neuroethics 5(2):173–184
Outram SM, Racine E (2011) Developing public health approaches to cognitive enhancement: an analysis of current reports. Public Health Ethics 4(1):93–105
Perner J, Lang B (1999) Development of theory of mind and executive control. Trends Cogn Sci 3(9):337–344
Racine E, Forlin C (2008) Cognitive enhancement, lifestyle choice or misuse of prescription drugs? Ethics blind spots in current debates. Neuroethics 3(1):1–4
Repantis D, Schlattmann P, Laisney O, Heuser I (2010) Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res 62:187–206
Roco MC, Bainbridge W (2002) Converging technologies for improving human performance: nanotechnology, biotechnology, information technology, and cognitive science. The National Science Foundation, Arlington
Roco MC, Bainbridge W, Tonn B, Whitesides G (eds) (2013) Convergence of knowledge, technology and society: beyond convergence of nano-bio-info-cognitive technologies, NBIC2, Springer, Dordrecht
Rosenthal D (2000) Consciousness, content, and metacognitive judgments. Conscious Cogn 9:203–214
Singh I (2008) Beyond polemics: science and ethics of ADHD. Nat Rev Neurosci 9:957–964
Tversky A, Kahneman D (1981) The framing of decisions and the psychology of choice. Science 211:453–458
Wolpe PR (2002) Treatment, enhancement, and the ethics of neurotherapeutics. Brain Cogn 50:387–395
Wynne B (1992) Misunderstood misunderstanding: social identities and the public uptake of science. Public Underst Sci 1:281–304
Young S, Amarasinghe JM (2010) Practitioner review: non-pharmacological treatment for ADHD: a lifespan approach. J Child Psychol Psychiatry 52(2):116–133
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this entry
Cite this entry
Khushf, G. (2016). Ethics of Convergence for Enhancement of Cognition. In: Bainbridge, W., Roco, M. (eds) Handbook of Science and Technology Convergence. Springer, Cham. https://doi.org/10.1007/978-3-319-07052-0_50
Download citation
DOI: https://doi.org/10.1007/978-3-319-07052-0_50
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-07051-3
Online ISBN: 978-3-319-07052-0
eBook Packages: Computer ScienceReference Module Computer Science and Engineering